These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 238542)

  • 41. [The influence of long term dipyridamole application on the coronary flow and isoproterenol and papaverine effects on the isolated hearts of small mammals].
    Mentz P; Förster W; Wartner U
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):317-24. PubMed ID: 4778622
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthin on the -adrenergic receptors and on the activity of isoprenaline.
    Boksay I; Bollmann V
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):174-80. PubMed ID: 5123864
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of etafenone on total and regional myocardial blood flow.
    Flohr H; Breull W
    Arzneimittelforschung; 1975 Sep; 25(9):1400-3. PubMed ID: 23
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of lanthanum on isoproterenol-induced activation of myocardial phosphorylase.
    Bockman EL; Rubio R; Berne RM
    Am J Physiol; 1973 Aug; 225(2):438-43. PubMed ID: 4722407
    [No Abstract]   [Full Text] [Related]  

  • 45. Metabolism of [3H]-(+/-)-isoprenaline by isolated atria and coronary arteries of the kitten.
    Cornish EJ; Goldie RG
    Br J Pharmacol; 1980 Mar; 68(3):499-504. PubMed ID: 7052341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of methylxanthine sensitization of norepinephrine responses in a coronaryartery.
    Kalsner S; Frew RD; Smith GM
    Am J Physiol; 1975 Jun; 228(6):1702-7. PubMed ID: 1155601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Vmax of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium.
    Kohlhardt M; Seifert C
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):55-62. PubMed ID: 6113549
    [No Abstract]   [Full Text] [Related]  

  • 48. 4(5)-(2-Amino-1-hydroxyalkyl)imidazoles.
    Bernabé M; Burger A
    J Med Chem; 1971 Sep; 14(9):883-5. PubMed ID: 4400867
    [No Abstract]   [Full Text] [Related]  

  • 49. [Non-specific actions of p-hydroxypropiophenones--potential beta adrenolytics].
    Cizmáriková R; Mlynarcík D; Greksáková O; Racanská E
    Pharmazie; 1990 Feb; 45(2):142-3. PubMed ID: 1971116
    [No Abstract]   [Full Text] [Related]  

  • 50. Papaverine analogs. VII. Studies on the time of onset of coronary dilator action.
    HANNA C
    Arch Int Pharmacodyn Ther; 1959 Mar; 119(1-2):162-7. PubMed ID: 13628273
    [No Abstract]   [Full Text] [Related]  

  • 51. [Khellin, relaxing agent of smooth muscle; elective action on the coronary vessels].
    AUBERTIN E
    J Med Bord; 1950 Dec; 127(12):821-3. PubMed ID: 14803897
    [No Abstract]   [Full Text] [Related]  

  • 52. Mechanism of the relaxing effect of adrenaline on bovine coronary vessels.
    MOHME-LUNDHOLM E
    Acta Physiol Scand; 1957 Mar; 38(3-4):255-64. PubMed ID: 13410623
    [No Abstract]   [Full Text] [Related]  

  • 53. [Coronary dilator effect of plant extracts].
    NIESCHULZ O; POPENDIKER K
    Arzneimittelforschung; 1957 Feb; 7(2):142-3. PubMed ID: 13412599
    [No Abstract]   [Full Text] [Related]  

  • 54. Differentiation of intestinal smooth muscle relaxation caused by drugs that inhibit phosphodiesterase.
    Pöch G; Umfahrer W
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jun; 293(3):257-68. PubMed ID: 183155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Modification of the cardiostimulatory and coronary dilator effect of isopreenaline caused by etafenone].
    Kukovetz WR
    Arzneimittelforschung; 1975 Jan; 25(1):31-8. PubMed ID: 238542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacological Properties of Fendiline in Cardiac and Smooth Muscle (author's transl)].
    Kukovetz WR; Pöch G; Holzmann S; Paietta E
    Arzneimittelforschung; 1976; 26(7):1321-30. PubMed ID: 1036917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Inhibition of the slow-response action potential of mammalian ventricular myocardium by etafenone (author's transl)].
    Kohlhardt M
    Arzneimittelforschung; 1979; 29(2):218-21. PubMed ID: 582134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The mechanism of action of bencyclane on smooth musculature].
    Kukovetz WR; Pöch G; Holzmann S; Paietta E
    Arzneimittelforschung; 1975 May; 25(5):722-6. PubMed ID: 170943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of calcium antagonist, etafenone hydrochloride, on the isolated guinea pig tracheal tissues.
    Kitamura S; Ishihara Y
    Arzneimittelforschung; 1980; 30(7):1088-91. PubMed ID: 7191291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.